DashboardAll companies
Run this on your own research
Common Stock · Common Stock

Sam Chun Dang Pharm Co., Ltd.

000250KRX₩182,700−₩5,900 (−3.13%)Market closed

Price Chart

Daily

Key facts

Market Cap
₩4.29T
P/E
808.4x
P/B
15.41x
ROE
1.9%

Sam Chun Dang Pharm Co., Ltd.

Common Stock · Common Stock · FY 2025

Sam Chun Dang Pharm Co., Ltd. is a notable pharmaceutical company involved in the research, development, and production of various healthcare solutions. Founded in South Korea, the company focuses on creating a diverse array of pharmaceutical products that cater to the healthcare needs of a broad spectrum of patients. Their portfolio includes over-the-counter drugs, prescription medications, and a range of health supplements, demonstrating their commitment to improving public health and optimizing therapeutic outcomes. By participating actively in the pharmaceutical industry, Sam Chun Dang Pharm Co., Ltd. contributes significantly to the accessibility and availability of essential medications across regional and global markets. The company consistently invests in innovation and manufacturing excellence, ensuring compliance with international regulatory standards and thereby enhancing its market reputation. Its role in the healthcare sector is pivotal, as it addresses critical medical needs and supports the overall advancement of medical sciences.

CEO
전인석
Employees
0
Website
scd.co.kr

Company Statistics

Valuation

P/E
808.4x
P/B
15.41x
P/S
18.35x
EV/EBITDA
191.5x
P/FCF
−85.4x

Margins

Gross
47.2%
EBITDA
9.7%
Operating
3.7%
Pre-Tax
5.4%
Net
5.2%

Returns

ROA
2.2%
ROE
1.9%
ROIC
2.5%

Growth (CAGR)

Rev 3Yr
9.3%
Rev 5Yr
6.8%
Op Inc 3Yr
−11.5%
Net Inc 3Yr
10.9%

Financial Health

Cash & Cash Equivalents
₩95.94B
Net Debt
₩101.69B
Debt/Equity
54.4%
Interest Cov
—

Profile

Revenue
₩231.81B
Shares Out
23.5M
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Sam Chun Dang Pharm Co., Ltd. (000250) Stock Forecast 2026 ₩182,700 — Price, Financials & Analyst Targets | AlphaLenz